Industry: Gene Therapy
Investors Number: 12
Technology: Neurological Disorders
Last Funding Type: Venture - Series Unknown
Headquarters: Ann Arbor, Michigan, United States
Founded Date: 2009
Funding Status: M&A
Total Funding: $106M
Estimated Revenue: Less than $1M